The decision, issued without the input of an official advisory committee, revises long-held labeling on the drugs cautioning ...
FDA seeks to lift “black box" warnings from menopause hormone therapy, citing evidence that benefits outweigh risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback